Another study has proved that in a well-established HCC xenograft model, the number of lung metastasis nodules is much higher in the ERO1L-overexpressing group, in comparation with the control group, which means ERO1L has the ability to promote HCC metastasis [11]. The gene discussed is ERO1A; the disease is hepatocellular carcinoma.